2147 studies found for:    ovarian cancer
Show Display Options
Rank Status Study
21 Not yet recruiting Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Other: PET/CT(3hours]
22 Recruiting Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Intervention: Procedure: Tumor Debulking Surgery (surgery in recurrent ovarian disease)
23 Completed Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study
Condition: Ovarian Cancer
Intervention: Procedure: DCE-MRI scans
24 Terminated NYU Ovarian Cancer Early Detection Program Blood and Genetics
Condition: Ovarian Cancer
Intervention:
25 Recruiting Chk1/2 Inhibitor (LY2606368) in Women With BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Non-High Risk Triple Negative Breast Cancer, and High Grade Serous Ovarian Cancer at Low Genetic Risk
Conditions: Ovarian Cancer;   Breast Cancer
Intervention: Drug: LY2606368
26 Terminated Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer
Conditions: Ovarian Cancer;   Epithelial Ovarian Cancer;   Fallopian Tube Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Drug: Lenalidomide, Liposomal Doxorubicin, Bevacizumab;   Drug: Revlimid, Doxil, Avastin
27 Terminated
Has Results
Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers
Conditions: Cancer;   Neuroendocrine;   Ovarian Cancer;   Colon Cancer
Interventions: Drug: JI-101;   Drug: Everolimus
28 Recruiting Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Procedure: ovarian cancer surgery
29 Active, not recruiting AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer
Conditions: Breast Cancer;   Ovarian Cancer
Intervention: Drug: AZ2281 + Carboplatin
30 Completed Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Genetic: protein expression analysis;   Other: immunohistochemistry
31 Active, not recruiting Chemotherapy-Related Toxicities In Ovarian Cancer Patients
Condition: Ovarian Cancer
Interventions: Behavioral: Interview;   Behavioral: Questionnaire
32 Active, not recruiting M. D. Anderson Symptom Inventory - Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Behavioral: Interview;   Behavioral: Survey
33 Not yet recruiting BRCA-Screening in Ovarian Cancer
Conditions: BRCA Status;   Ovarian Cancer
Intervention: Genetic: Testing of BRCA status regarding germline and somatic mutation
34 Terminated Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Intervention: Procedure: Seprafilm™
35 Active, not recruiting Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
Conditions: Breast Cancer;   Fallopian Tube Cancer;   Ovarian Neoplasm;   Primary Peritoneal Cavity Cancer
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Procedure: study of high risk factors;   Procedure: evaluation of cancer risk factors
36 Recruiting First Line Ovarian Cancer Treatment - Cohort Study
Condition: Epithelial Ovarian Cancer
Intervention: Drug: Bevacizumab
37 Unknown  Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis
Conditions: Ovarian Cancer;   Peritoneal Metastasis
Intervention: Procedure: intravenous contrast administration
38 Active, not recruiting Sexual Functioning After Primary Treatment of Ovarian Cancer
Conditions: Ovarian Cancer;   Sexual Dysfunction
Intervention: Behavioral: questionnaires
39 Terminated Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand
Condition: Ovarian Cancer
Intervention: Drug: EC-17
40 Active, not recruiting Activity, Tolerability, Safety of Temsirolimus in Women With Ovarian Cancer Who Progressed During Previous Platinum Chemotherapy or Within 6 Months After Therapy or Advanced Endometrial Carcinoma
Conditions: Genital Diseases, Female;   Ovarian Diseases;   Ovarian Neoplasms;   Endometrial Neoplasms
Intervention: Drug: Temsirolimus

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years